RNA-seq analysis reveals unique transcriptome signatures in systemic lupus erythematosus patients with distinct autoantibody specificities

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Rai, Richa ^a   Chauhan, Sudhir Kumar ^a   Singh, Vikas Vikram ^a   Rai, Madhukar ^b   Rai, Geeta ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CELL NUCLEUS ANTIGEN; CYTOKINE; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHO FACTOR; TRANSCRIPTOME; ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GRANULOCYTE; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOREGULATION; PATIENT CODING; PLASMA CELL; RNA SEQUENCE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTOMICS; BLOOD; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; YOUNG ADULT;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ANTIGENS, NUCLEAR; AUTOANTIBODIES; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; TRANSCRIPTOME; YOUNG ADULT;

EID: 84994711822     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0166312     Document Type: Article

References (88)

1. Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: A critical review. J Autoimmun. 2014; 48-49: 10-3. doi: 10.1016/j.jaut.2014.01.004 PMID: 24461385.
2. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004; 34 (2):501-37. PMID: 15505768.
3. Rus V, Atamas SP, Shustova V, Luzina IG, Selaru F, Magder LS, et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol. 2002; 102(3):283-90. PMID: 11890715. doi: 10.1006/clim.2001.5182
4. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 2003; 4(3):177-86. PMID: 12700592. doi: 10.1038/sj.gene.6363966
5. Ye S, Pang H, Gu YY, Hua J, Chen XG, Bao CD, et al. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology (Oxford). 2003; 42(10):1155-63. PMID: 12777642. doi: 10.1093/rheumatology/keg315
6. Rus V, Chen H, Zernetkina V, Magder LS, Mathai S, Hochberg MC, et al. Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol. 2004; 112(3):231-4. PMID: 15308115. doi: 10.1016/j.clim.2004.06.005
7. Nakou M, Knowlton N, Frank MB, Bertsias G, Osban J, Sandel CE, et al. Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. Arthritis Rheum. 2008; 58(11):3541-9. doi: 10.1002/art.2396 PMID: 18975309. PMCID: PMC2760826.
8. Shi L, Zhang Z, Yu AM, Wang W, Wei Z, Akhter E, et al. The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS One. 2014; 9(5):e93846. doi: 10.1371/journal.pone.0093846. eCollection 2014 PMID: 24796678. PMCID: PMC4010412.
9. Zhao M, Liu S, Luo S, Wu H, Tang M, Cheng W, et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun. 2014; 54:127-36. doi: 10.1016/j.jaut.2014.07.002 PMID: 25091625.
10. Rai G, Rai R, Saeidian AH, Rai M. Microarray to deep sequencing: Transcriptome and mirna profiling to elucidate molecular pathways in systemic lupus erythematosus. Immunol Res. 2015. doi: 10.1007/ s12026-015-8672-y PMID: 26188428.
11. Ellyard JI, Jerjen R, Martin JL, Lee AY, Field MA, Jiang SH, et al. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing. Arthritis Rheumatol. 2014; 66(12):3382-6. PMID: 25138095. doi: 10.1002/art.38824
12. Van Eyck L, De Somer L, Pombal D, Bornschein S, Frans G, Humblet-Baron S, et al. Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency. Arthritis Rheumatol. 2015; 67(6):1592-7. doi: 10.1002/art.39110 PMID: 25777993.
13. Chauhan SK, Singh VV, Rai R, Rai M, Rai G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J Clin Immunol. 2013; 33 (5):954-64. doi: 10.1007/s10875-013-9887-0 PMID: 23564191.
14. Rai R, Chauhan SK, Singh VV, Rai M, Rai G. Rai, Heat shock protein 27 and its regulatory molecule express differentially in SLE patients with distinct autoantibody profiles. Immunol Lett. 2015; 164 (1):25-32. doi: 10.1016/j.imlet.2015.01.007 PMID: 25655337.
15. Chauhan SK, Singh VV, Rai R, Rai M, Rai G. Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities. J Clin Immunol. 2014; 34(4):491-503. PMID: 24659206. doi: 10.1007/s10875-014-0008-5
16. Chauhan SK, Rai R, Singh VV, Rai M, Rai G. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities. Immunol Lett. 2015; 168(2):254-9. doi: 10.1016/j.imlet.2015.09.016 PMID: 26434792.
17. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002; 29(2):288-91. PMID: 11838846.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. PMID: 11846609. doi: 10.1006/ meth.2001.1262
19. Karapetyan AR, Buiting C, Kuiper RA, Coolen MW. Regulatory Roles for Long ncRNA and mRNA. Cancers (Basel). 2013; 5(2):462-90. doi: 10.3390/cancers5020462 PMID: 24216986. PMCID: PMC3730338.
20. Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008; 58(6):1762-73. doi: 10.1002/art.23498 PMID: 18512812.
21. Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, et al. Correlation between circulating CD27 high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2003; 48(5):1332-42. doi: 10.1002/art.10949 PMID: 12746906.
22. Tarte K, Zhan F, De Vos J, Klein B, Shaughnessy J Jr. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 2003; 15; 102(2):592-600. doi: 10.1182/blood-2002-10-3161 PMID: 12663452.
23. Lugar PL, Love C, Grammer AC, Dave SS, Lipsky PE. Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS One. 2012; 7(9):e44362. doi: 10. 1371/journal.pone.0044362 PMID: 23028528. PMCID: PMC3448624.
24. Jacob N, Stohl W. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther. 2011; 13(4):228. doi: 10.1186/ar3349 PMID: 21745419. PMCID: PMC3239336.
25. Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol. 1999; 18(1):17-22. PMID: 10088943.
26. Gröndal G, Gunnarsson I, Rönnelid J, Rogberg S, Klareskog L, Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 2000; 18(5):565-70. PMID: 11072595.
27. Kidani Y, Bensinger SJ. Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus. J Clin Invest. 2014; 124(2):482-5. doi: 10.1172/JCI74141 PMID: 24463443. PMCID: PMC3904634.
28. Moulton VR, Tsokos GC. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res Ther. 2011; 13(2):207. doi: 10.1186/ar3251 PMID: 21457530. PMCID: PMC3132009.
29. Ivanov VN, Nikolić-Zugić J. Transcription factor activation during signal-induced apoptosis of immature CD4(+)CD8(+) thymocytes. A protective role of c-Fos. J Biol Chem. 1997; 272(13):8558-66. PMID: 9079686.
30. Kyttaris VC, Zhang Z, Kampagianni O, Tsokos GC. Calcium signaling in systemic lupus erythematosus T cells: A treatment target. Arthritis Rheum. 2011; 63(7):2058-66. doi: 10.1002/art.30353 PMID: 21437870.
31. Sipka S, Szucs K, Szántó S, Kovács I, Lakos G, Kiss E, et al. Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Ann Rheum Dis. 2001; 60(4):380-4. PMID: 11247869. PMCID: PMC1753622. doi: 10. 1136/ard.60.4.380
32. Mosca M, Tani C, Carli L, Bombardieri S. Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol. 2011; 29(5 Suppl 68):S126-9. PMID: 22018198.
33. Li Y, Zhao M, Yin H, Gao F, Wu X, Luo Y, et al. Overexpression of the growth arrest and DNA damageinduced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 2010; 62(5):1438-47. doi: 10.1002/art.27363 PMID: 20131288.
34. Maroder M, Bellavia D, Meco D, Napolitano M, Stigliano A, Alesse E, et al. Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol. 1996; 157(7):2864-72. PMID: 8816391.
35. Ikenouchi-Sugita A, Yoshimura R, Ueda N, Kodama Y, Umene-Nakano W, Nakamura J. Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes. Neuropsychiatr Dis Treat. 2008; 4 (6):1277-81. PMID: 19337469. PMCID: PMC2646658.
36. Tamashiro LF, Oliveira RD, Oliveira R, Frota ER, Donadi EA, Del-Ben CM, et al. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford). 2014; 53(12):2182-90. doi: 10.1093/rheumatology/keu251 PMID: 24942492.
37. Kawano M, Seya T, Koni I, Mabuchi H. Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1999; 116 (3):542-6. PMID: 10361248. PMCID: PMC1905304. doi: 10.1046/j.1365-2249.1999.00917.x
38. Alegretti AP, Schneider L, Piccoli AK, Monticielo OA, Lora PS, Brenol JC, et al. Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients. Clin Dev Immunol. 2012; 2012:725684. doi: 10.1155/2012/725684 PMID: 22761633. PMCID: PMC3385850.
39. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus. 2000; 9(9):664-71. PMID: 11199920.
40. Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: All roads lead to type I interferons. Curr Opin Immunol. 2006; 18(6):676-82. PMID: 17011763. doi: 10.1016/j.coi.2006.09.014
41. Zhang Z, Shi L, Song L, Ephrem E, Petri M, Sullivan KE. Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus. Arthritis Rheumatol. 2015; 67(3):785-96. doi: 10.1002/art.38964 PMID: 25418955. PMCID: PMC4342285.
42. Wu T, Qin X, Kurepa Z, Kumar KR, Liu K, Kanta H, et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest. 2007; 117(8):2186-96. PMID: 17641780. PMCID: PMC1913486. doi: 10.1172/JCI30398
43. Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis. 2006; 64(1-2):45-50. PMID: 17121489.
44. Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006; 39(1):63-70. PMID: 16455583. doi: 10.1080/ 08916930500484849
45. Wu T, Xie C, Han J, Ye Y, Weiel J, Li Q, et al. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One. 2012; 7(6):e37210. doi: 10.1371/journal.pone.0037210 PMID: 22723834. PMCID: PMC3378560.
46. Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, et al. Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clin Dev Immunol. 2012; 2012:826182. doi: 10.1155/2012/826182 PMID: 22966240. PMCID: PMC3433142.
47. Tsumiyama K, Takimoto M, Shiozawa S, Requirement of antigen cross-presentation for lupus tissue injuries: essential role of endosomal trafficking and proteosomal degradation. J Immunol. 2011; 186 (Meeting Abstract Supplement) 44.24.
48. Jury EC, Flores-Borja F, Kalsi HS, Lazarus M, Isenberg DA, Mauri C, et al. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur J Immunol. 2010; 40(2):569-78. doi: 10.1002/eji.200939781 PMID: 19950182.
49. Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 2009; 60(6):1753-63. doi: 10. 1002/art.24556 PMID: 19479851
50. Bezman NA, Cedars E, Steiner DF, Blelloch R, Hesslein DG, Lanier LL. Distinct requirements of micro RNAs in NK cell activation, survival, and function. J Immunol. 2010; 185(7):3835-46. doi: 10.4049/ jimmunol.1000980 PMID: 20805417. PMCID: PMC2943981.
51. Sullivan RP, Leong JW, Schneider SE, Keppel CR, Germino E, French AR, et al. MicroRNA-deficient NK cells exhibit decreased survival but enhanced function. J Immunol. 2012; 188(7):3019-30. doi: 10. 4049/jimmunol.1102294 PMID: 22379033. PMCID: PMC3311726.
52. Seitz HM, Matsushima GK. Dendritic cells in systemic lupus erythematosus. Int Rev Immunol. 2010; 29 (2):184-209. doi: 10.3109/08830181003602507 PMID: 20367140. PMCID: PMC2892226.
53. Jeffries MA, Dozmorov M, Tang Y, Merrill JT, Wren JD, Sawalha AH. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics. 2011; 6 (5):593-601. PMID: 21436623. PMCID: PMC3121972. doi: 10.4161/epi.6.5.15374
54. Perl A, Gergely P Jr, Banki K. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int Rev Immunol. 2004; 23(3-4):293-313. PMID: 15204090. doi: 10.1080/ 08830180490452576
55. Perl A, Hanczko R, Doherty E. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Biol. 2012; 900:61-89. doi: 10.1007/978-1-60761-720-4- 4 PMID: 22933065.
56. Akisaka T, Yoshida H, Inoue S, Shimizu K. Organization of cytoskeletal F-actin, G-actin, and gelsolin in the adhesion structures in cultured osteoclast. J Bone Miner Res. 2001; 16(7):1248-55. PMID: 11450700. doi: 10.1359/jbmr.2001.16.7.1248
57. Frost PG, Lachmann PJ. The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin Exp Immunol. 1968; 3(5):447-55. PMID: 5662583. PMCID: PMC1578906.
58. Hadjiyannaki K, Lachmann PJ. The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB-NZW mice. Clin Exp Immunol. 1972; 11(2):291-5. PMID: 4557183. PMCID: PMC1553626.
59. Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010; 107 (21):9813-8. doi: 10.1073/pnas.0909927107 PMID: 20439745. PMCID: PMC2906830.
60. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003; 197(6):711-23. PMID: 12642603. PMCID: PMC2193846. doi: 10.1084/jem.20021553
61. Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, et al. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell. 2016; 165(3):551-65. PMID: 27040498. doi: 10.1016/j.cell.2016.03.008
62. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005; 52(5):1491-503. PMID: 15880830. doi: 10.1002/art.21031
63. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol. 2005; 24(2):178-81. PMID: 15565395. doi: 10.1007/s10067-004-1024-2
64. Mohamed AAA, Md Yusof MY, El-Sherbiny Y, Emery P, Vital EM. Interferon Activity in Early and Established SLE: Interferon Score Is Lower in Early Disease and Not Seen without Antibodies to Extractable Nuclear Antigens [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10).
65. Darrah E, Andrade F. NETs: The missing link between cell death and systemic autoimmune diseases? Front Immunol. 2012; 3:428. doi: 10.3389/fimmu.2012.00428. eCollection 2012 PMID: 23335928. PMCID: PMC3547286.
66. Leffler J, Martin M, Gullstrand B, Tydén H, Lood C, Truedsson L, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol. 2012; 188(7):3522-31. doi: 10.4049/jimmunol.1102404 PMID: 22345666.
67. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000; 165:5970-5979. PMID: 11067960.
68. Huang W, Sinha J, Newman J, Reddy B, Budhai L, Furie R, et al. The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus. Arthritis Rheum. 2002; 46(6):1554-62. doi: 10.1002/art.10273 PMID: 12115186.
69. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A. 2006; 27; 103(26):9970-5. doi: 10.1073/pnas. 0603912103 PMID: 16777955. PMCID: PMC1502563.
70. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med. 2005; 18; 202(2):321-31. doi: 10.1084/jem.20050338 PMID: 16027240. PMCID: PMC2212997.
71. De La Torre M, Urra JM, Blanco J. Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity? Lupus. 2009; 18(3):216-22. doi: 10.1177/0961203308096068 PMID: 19213859.
72. Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, et al. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Lupus. 2015; 1257-66. doi: 10.1177/ 0961203315585815 PMID: 25966926.
73. Hrycek A, Kusmierz D, Dyba?a T, Swiatkowska L. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity. 2007; 40(1):23-30. PMID: 17364494. doi: 10.1080/08916930601168093
74. Beşliu AN, Pistol G, Marica CM, Bǎnicǎ LM, Chiţonu C, Ionescu R, et al. PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients. Roum Arch Microbiol Immunol. 2009; 68 (2):69-79. PMID: 20361524.
75. Kawasaki M, Fujishiro M, Yamaguchi A, Nozawa K, Kaneko H, Takasaki Y, et al. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus. 2011; 20(12):1231-9. doi: 10.1177/0961203311409963 PMID: 21980035.
76. Xiong W, Lahita RG. Novel treatments for systemic lupus erythematosus. Ther Adv Musculoskelet Dis. 2011; 3(5):255-66. doi: 10.1177/1759720X11415456 PMID: 22870484. PMCID: PMC3383530.
77. Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Vardaki E, Perakis K, et al. The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. Nephrol Dial Transplant. 2011; 26(2):498-508. doi: 10.1093/ndt/gfq496 PMID: 20709738.
78. Cedeño S, Cifarelli DF, Blasini AM, Paris M, Placeres F, Alonso G, et al. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol. 2003; 106(1):41-9. PMID: 12584050.
79. Becker AM, Dao KH, Han BK, Kornu R, Lakhanpal S, Mobley AB, et al. SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One. 2013; 8(6):e67003. doi: 10.1371/journal.pone.0067003 PMID: 23826184. PMCID: PMC3691135.
80. Yin X, Knecht DA, Lynes MA. Metallothionein mediates leukocytechemotaxis. BMC Immunol. 2005; 6:21. PMID: 16164753. PMCID: PMC1262721. doi: 10.1186/1471-2172-6-21
81. Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, et al. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol. 2009; 36(12):2682-90. doi: 10.3899/jrheum.090338 PMID: 19884269. PMCID: PMC2803319.
82. Rupper A, Grove B, Cardelli J. Rab7 regulates phagosome maturation in dictyostelium. J Cell Sci. 2001; 114(Pt 13):2449-60. PMID: 11559753.
83. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41(7):1241-50. PMID: 9663482. doi: 10.1002/1529-0131(199807) 41:7<1241::AID-ART15>3.0.CO;2-H
84. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003; 48(10):2888-97. PMID: 14558095. doi: 10.1002/art.11237
85. Huber AR, Kunkel SL, Todd RF 3rd, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991; 254(5028):99-102. PMID: 1718038.
86. Seyednasrollah F, Laiho A, Elo LL. Comparison of software packages for detecting differential expression in RNA-seq studies. Brief Bioinform. 2015; 16(1):59-70. doi: 10.1093/bib/bbt086 PMID: 24300110. PMCID: PMC4293378.
87. Zhang ZH, Jhaveri DJ, Marshall VM, Bauer DC, Edson J, Narayanan RK, et al. A comparative study of techniques for differential expression analysis on RNA-Seq data. PLoS One. 2014; 13; 9(8):e103207. doi: 10.1371/journal.pone.0103207. eCollection 2014 PMID: 25119138. PMCID: PMC4132098.
88. Hara M, Kitani A, Harigai M, Hirose T, Norioka K, Hirose W, et al. Differential abnormality in cell-cycle stage of peripheral B cells from patients with systemic lupus erythematosus. Rheumatol Int. 1987; 7 (2):83-7. PMID: 3497423.